News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Halstead Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/13/2023 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 16,708 shares
@ $0
Sold 14,208 shares
@ $43.2, valued at
$613.8k
Sold 2,500 shares
@ $42.52, valued at
$106.3k
Sold 6,868 shares
@ $44.99, valued at
$309k
Sold 476 shares
@ $44.15, valued at
$21k
Exercised 7,344 restricted stock units
@ $0 |
|
| 03/08/2023 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 39,398 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 7,906 shares
@ $47.03, valued at
$371.8k
Exercised 7,906 restricted stock units
@ $0 |
|
| 02/22/2023 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 9,296 shares
@ $46.56, valued at
$432.8k
Sold 643 shares
@ $47.23, valued at
$30.4k
Sold 1,100 shares
@ $48.68, valued at
$53.5k
Sold 100 shares
@ $49.6, valued at
$5k
Exercised 11,139 restricted stock units
@ $0 |
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 17,916 options to buy
@ $56.73, valued at
$1M
Granted 22,034 restricted stock units
@ $0 |
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 6,589 shares
@ $55.69, valued at
$366.9k
Sold 4,550 shares
@ $54.98, valued at
$250.2k
Exercised 11,139 restricted stock units
@ $0 |
|
| 01/11/2022 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 2,504 shares
@ $41.74, valued at
$104.5k
Sold 12,755 shares
@ $40.81, valued at
$520.5k
Sold 4,380 shares
@ $40.12, valued at
$175.7k
Exercised 19,639 restricted stock units
@ $0 |
|
| 12/23/2021 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 22,620 shares
@ $48.62, valued at
$1.1M
Sold 104,775 shares
@ $47.84, valued at
$5M
Sold 36,434 shares
@ $46.87, valued at
$1.7M
Sold 8,690 shares
@ $45.74, valued at
$397.5k
Sold 4,344 shares
@ $44.87, valued at
$194.9k
Exercised 25,000 options to buy
@ $13.86, valued at
$346.5k
Exercised 88,146 options to buy
@ $17.57, valued at
$1.5M
Exercised 63,717 options to buy
@ $15.73, valued at
$1M
|
|
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2020 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 75,664 shares
@ $27.6, valued at
$2.1M
Sold 3,761 shares
@ $27.95, valued at
$105.1k
Exercised 75,000 options to buy
@ $13.86, valued at
$1M
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 8,043 shares
@ $0
Disposed of 3,809 shares
@ $23.61, valued at
$89.9k
|
|
| 01/10/2020 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 19,638 shares
@ $26.16, valued at
$513.7k
|
|
| 01/08/2020 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 3,945 shares
@ $29.8, valued at
$117.6k
Sold 17,513 shares
@ $30.46, valued at
$533.4k
Exercised 19,638 restricted stock units
@ $0 |
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 16,060 shares
@ $11.34, valued at
$182.1k
Sold 5,398 shares
@ $11.8, valued at
$63.7k
Sold 3,108 shares
@ $12.42, valued at
$38.6k
Exercised 3,108 restricted stock units
@ $0
Granted 80,951 options to buy
@ $12.73, valued at
$1M
Granted 58,915 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 7,807 shares
@ $0
Sold 7,807 shares
@ $11.09, valued at
$86.6k
Exercised 5,298 restricted stock units
@ $0
Exercised 16,160 restricted stock units
@ $0 |
|
| 01/24/2018 |
4
| Halstead Michael (SVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Sold 25,500 shares
@ $18.03, valued at
$459.8k
|
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2017 |
4
| Halstead Michael (SVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc. |
| 01/05/2017 |
4
| Halstead Michael (SVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc. |
| 01/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2015 |
4
| Halstead Michael (SVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 88,146 options to buy
@ $17.57, valued at
$1.5M
|
|
| 11/06/2014 |
4
| Halstead Michael (SVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Bought 7,000 shares
@ $15.21, valued at
$106.5k
Bought 13,000 shares
@ $15.47, valued at
$201.1k
|
|
| 07/31/2014 |
4
| Halstead Michael (SVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.|
Txns:
| Granted 100,000 options to buy
@ $13.86, valued at
$1.4M
|
|
| 10/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2013 |
4
| Halstead Michael (Senior V.P., Corp. Development) has filed a Form 4 on Warner Chilcott plc|
Txns:
| Sold 1,747 shares
@ $13.4637, valued at
$23.5k
|
|
| 02/21/2013 |
4
| Halstead Michael (Senior V.P., Corp. Development) has filed a Form 4 on Warner Chilcott plc|
Txns:
| Sold 419 shares
@ $14.5277, valued at
$6.1k
|
|
|
|
|